$60.95
Closed
$0.23(0.39%)

At close

About

Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. The company is headquartered in Charlotte, North Carolina and currently employs 8,300 full-time employees. The Company’s segments include Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. Its Specialties business optimizes its portfolio of bromine and highly specialized lithium solutions. Its Specialties business serves a variety of industries, including energy, mobility, connectivity, and health. Specialty products are essential in both internal combustion and electric vehicles, from high-voltage cables and powertrains to airbags and tires. Its Ketjen segment includes clean fuels technologies (CFT), fluidized catalytic cracking (FCC) catalysts and additives, and performance catalyst solutions (PCS). The company serves various markets such as grid storage, automotive, aerospace, conventional energy, and others.
Country

US

CEO

Mr. Jerry Masters

IPO date

1994

Employees

8,300

ISIN

US0126531013

Key stats

Open

$82.81

Volume

227.04M

Market cap

$7.14B

Prev. close

$60.96

Impl / hst vl

-

Open interest

$0.00

$0.00

Day’s Range

$0.00

$49.43

52W Range

$113.91

Valuation

44
Valuation score
Fairly Valued
P/E
-
P/S
1.66
P/B
0.84
Current ratio
2.11
Debt / Equity
0.20
ROE
-11.01%
Gross margin
14.51%
Income growth
-101.01%
FCF growth
-202.17

Jul

1

Dividends

The last payment date was Jul 1, 2025

Div. per Share

$0.41

Div. Yield

1.09%

Payout Ratio

-

Div. Growth YoY

-

Analysts estimates

Consensus rating
Hold

The average rating from top 31 analysts indicates that stock may significantly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$83.10
The top 28 analysts forecasts that 12-month price may increase by 36.35%, with a low of $58.58 and a high of $162.75
$58.58
Low
$83.10
Avg
$162.75
High
Current price

Earnings

Q1 ‘25 revenue
$1.08B
Q1 ‘25 net income
-$340.00K
Revenue
Net income
Previous EPS
-
Estimate EPS
-$0.31
Actual EPS
Estimate EPS